NCT05816395View on ClinicalTrials.gov

Safety and Efficacy of RHH646 for Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

February 24, 2025

Study Completion Date

February 24, 2025

Conditions
Osteoarthritis, Knee
Interventions
DRUG

RHH646

RHH646 capsule for oral use

DRUG

Placebo

RHH646 placebo capsule for oral use

Trial Locations (10)

2730

Novartis Investigative Site, Herlev

9362

Novartis Investigative Site, Gandrup

15705

Novartis Investigative Site, Santiago de Compostela

32789

Conquest Research, Winter Park

77074

Clinical Trial Network, Houston

77479

Pioneer Research Solutions, Sugar Land

95648

Clinical Trials Research, Lincoln

C1015ABO

Novartis Investigative Site, Ciudad Autonoma de Bs As

C1055AAF

Novartis Investigative Site, Ciudad Autonoma de Bs As

00-874

Novartis Investigative Site, Warsaw

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY